DVM
AVNS

Dreman Value Management’s Avanos Medical AVNS Stock Holding History

Dreman Value Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-3,482
Closed -$116K – 554
2015
Q4 		$116K Sell
3,482
-966
-22% -$30K 0.04% 129
2015
Q3 		$127K Buy
4,448
+966
+28% +$33.7K 0.01% 342
2015
Q2 		$141K Buy
+3,482
New +$156K 0.01% 351

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
CI
Cambiar Investors Denver, Colorado $2.16B AUM 16.24% 1-Year Est. Return

Dreman Value Management's AVNS Position: Q1 2016 in Review

Dreman Value Management sold out of Avanos Medical (AVNS) in Q1 2016, closing a stake of 3,482 shares — an estimated $116K sold.

Dreman Value Management first reported a position in AVNS in Q2 2015 and held it in 3 quarters. The position peaked at $141K in Q2 2015. 333 funds tracked by Wall St. Rank hold AVNS as of Q1 2016.

  • Dreman Value Management reported no remaining Avanos Medical position as of Q1 2016 after selling out during the quarter.
  • Dreman Value Management sold 3,482 Avanos Medical shares in Q1 2016, an estimated $116K.
  • Dreman Value Management first reported a position in Avanos Medical in Q2 2015 and held it in 3 quarters.
  • Dreman Value Management's Avanos Medical position peaked at $141K in Q2 2015.
  • 333 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2016.

Based on Dreman Value Management's 13F filing for Q1 2016, filed 13 May 2016.